LONDON, Jan 21 – Oxford scientists are preparing to implement new versions of their vaccine to counteract the more infectious Covid-19 variants found in the UK, South Africa and Brazil, The Telegraph was reported yesterday.
The team behind the vaccine from Oxford and AstraZeneca Plc are conducting feasibility studies to redesign the technology, the newspaper said, citing confirmation from Oxford University.
The scientists were working on estimating how quickly they could redesign their ChAdOx vaccine platform, the report said.
AstraZeneca sent to Oxford for comment. A spokesman from Oxford said the university is carefully assessing the impact of new changes on vaccine immunity and evaluating the processes required for the rapid development of modified Covid-19 vaccines if these should be essential.
Separately, British Prime Minister Boris Johnson said yesterday that the country’s pharmaceutical regulator will be ready and able to approve new versions of Covid-19 vaccines designed to combat potential new variants of the coronavirus. appear.
Recent laboratory tests have shown that the Covid-19 vaccine developed by Pfizer Inc and its partner BioNTech SE is likely to work against the UK variant. spread all over the world.
BioNTech has stated that they plan to publish a more detailed study of the potential impact of the vaccine on the South African version within a few days.
AstraZeneca Plc, Moderna Inc and CureVac NV are also testing whether their individual views protect against the rapidly spreading changes. – Reuters